Abstract
Psoriasis can have a profound impact on a patient, interfering in all aspects of life. Therefore, measuring the impact of disease and the effects of treatment must include both physiologic measurements as well as health-related quality of life tools. Psychosocial evaluation of patients at risk allows for early interventions that will promote positive patient outcomes and compliance with the treatment pathways.
MeSH terms
-
Activities of Daily Living
-
Anti-Inflammatory Agents / therapeutic use
-
Attitude to Health
-
Body Image
-
Calcitriol / analogs & derivatives*
-
Calcitriol / therapeutic use
-
Health Status
-
Health Status Indicators
-
Humans
-
Nurse's Role
-
Nursing Diagnosis
-
PUVA Therapy
-
Patient Care Planning
-
Psoriasis / drug therapy
-
Psoriasis / nursing*
-
Psoriasis / psychology*
-
Quality of Life*
-
Self Concept
-
Social Isolation
-
Treatment Refusal
Substances
-
Anti-Inflammatory Agents
-
calcipotriene
-
Calcitriol